Yaz blood clot victim hopes to warn others
September 8th, 2010 by Jennifer Walker-Journey
When Mollie, a 31-year-old marathon runner, was diagnosed with bilateral pulmonary embolism, doctors immediately said it was because she was taking Yaz birth control pills. “While I was in the hospital my doctor told me he had 12 other girls – all under 35, non-smokers, active (not overweight), all on Yaz – who were admitted within the same week for clots in their lungs,” Mollie wrote on an eHealth forum. “Twelve girls in one week! At one hospital! I am shocked and don’t understand how this drug can still be on the market.”
It’s the same question thousands of woman are asking after suffering serious health problems they say were caused by Yaz and Yasmine birth control pills. The pills are a unique formulation that combine a new hormone called ethinyl estradiol with the diuretic drospirenone. Bayer Healthcare, the company that produces the pills, claimed the formulation not only prevented unwanted pregnancies, but also helped curb symptoms of premenstrual dysphoric disorder (PMDD) and moderate acne.
However, experts say the diuretic causes an increase in potassium levels that can lead to blood clots, which puts women at an increased risk of heart attack, stroke, pulmonary embolism, deep vein thrombosis, and even death. More than 2,000 women have filed suit against Bayer claiming they were not adequately warned that taking Yaz or Yasmin put them at risk for serious and life threatening health problems.
“There are a bunch of people out there (who have fallen ill after taking Yaz),” Mollie writes. “Let’s hope we can find them and make other girls aware just how dangerous Yaz really is.”
